Tirzepatide and Digestive Health: Nurturing Your Gut While on Treatment
Tirzepatide is a novel medication for treating type 2 diabetes, classified as a GLP-1 receptor agonist. It functions by promoting insulin release and reducing glucagon production, thereby lowering blood sugar levels and enhancing glycemic control. However, tirzepatide can affect digestive health, with common side effects including nausea, vomiting, diarrhea, and constipation. These effects are typically mild and often improve as… Read More »Tirzepatide and Digestive Health: Nurturing Your Gut While on Treatment















































